The U.S. Food and Drug Administration has granted marketing approval for Mozobil, Genzyme’s patented drug which stimulates the mobilization of autologous adult stem cells, now available for the treatment of non-Hodgkin’s lymphoma and multiple myeloma.
A new publication issued by the Vatican has high praise for adult stem cell research and therapies, but not for embryonic stem cell research.
While the treatment of people with stem cells is still somewhat of a controversial topic, veterinary applications of stem cell therapy are enjoying unbridled enthusiasm and success.
Researchers move one step closer to understanding the origin of prostate cancer cells.
Researchers at the Linheng Li Lab of the Stowers Institute have identified the precise location of the bone marrow stem cell niche, thereby solving a widely regarded mystery.
Adult stem cells derived from bone marrow have been shown to be therapeutic in the treatment of a rare skin disease.
